Scientia Vascular

What Scientia Vascular does

Scientia Vascular was a privately held medical device company headquartered in Salt Lake City, Utah that developed and commercialized neurovascular access devices for stroke and aneurysm treatment. The company was founded in 2007 by John Lippert and built a focused product portfolio consisting of high-performance guidewires, microcatheters, and aspiration catheters, all manufactured using proprietary microfabrication technology that enabled precise customization of surgical tools for navigating complex cerebral vasculature. The company's core technical differentiator was its microfabrication platform, which produced devices capable of reaching hard-to-access parts of the brain and reducing stroke treatment times by approximately 30 minutes compared to conventional approaches. Products were used in procedures for more than 90,000 patients annually prior to acquisition.

The company operated a B2B enterprise sales model, selling hardware devices directly to acute care hospitals and medical centers performing neurovascular interventions through a specialized field sales organization targeting interventional neuroradiologists and neurovascular surgeons. Revenue was generated through one-time hardware device sales with quote-based enterprise pricing, and the customer base was horizontally distributed across hospital accounts within the neurovascular procedure segment. The company had approximately 310 employees at the time of acquisition and had raised approximately $64 million in growth capital across a 2021 SEC Form D offering ($50M) and a September 2024 Piper Sandler Merchant Banking-led growth round ($14M).

In June 2026, Medtronic completed the acquisition of Scientia Vascular for $550 million plus potential earn-out and milestone payments, integrating the company's neurovascular access portfolio with Medtronic's existing therapeutic neurovascular suite. GlobalData projected the franchise could grow from approximately $45 million to $80-100 million if Medtronic successfully replicates US market success globally through its established international neurovascular sales network. All approximately 310 employees, including founder John Lippert who continued as CTO, transitioned to Medtronic as part of the acquisition.

Name

Scientia Vascular

Legal name

Scientia Vascular, LLC

Website

https://scientiavascular.com

Company type

Private

Founded year

2007

Operating status

Acquired

Headcount range

251–500 employees

Short description

Scientia Vascular is a medical device company that develops neurovascular access devices, including high-performance guidewires, microcatheters, and aspiration catheters, using proprietary microfabrication technology for stroke and aneurysm treatment in hospitals. Acquired by Medtronic in June 2026.

Ownership category

akta.pro rank

Product category

Neurovascular Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Vascular Access & Closure Devices (Sheaths, Guidewires, Closure Systems) (HLAHAFAK)

akta.pro secondary industry

Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ)

Keywords

• Neurovascular devices
• Medical guidewires
• Microcatheters
• Aspiration catheters
• Stroke treatment devices

Headquarters

HQ city

West Valley City

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Neurovascular Device Sales: Sale of advanced neurovascular tools including microcatheters, aspiration catheters, and guidewires to hospitals and medical centers for stroke and neurovascular disease treatment. Revenue generated through one-time hardware device sales.

Go-to-market motion2 records

Distribution channels1 record

Core offering

Scientia Vascular designs, manufactures, and sells neurovascular access medical devices—including high-performance guidewires, microcatheters, and aspiration catheters—used by hospitals and interventional neuroradiologists to navigate complex cerebral anatomy during stroke and aneurysm procedures. The products are built using proprietary microfabrication technology that enables precise customization of surgical tools for the brain's vasculature.

Product overview

Scientia Vascular is a neurovascular medical device company that offers a portfolio of access products for stroke and neurovascular procedures. The core product portfolio consists of high-performance guidewires, microcatheters, and aspiration catheters designed to work together as an integrated procedural workflow. The company leverages proprietary microfabrication technologies to create precisely customized surgical tools for navigating the complex anatomy of the brain. These access products are designed to address challenges in reaching and treating hard-to-access parts of the cerebral vasculature during stroke and aneurysm procedures, with the goal of reducing treatment times and improving patient outcomes.

Differentiator

Problem solved

Functional benefit

Products and services

• Neurovascular Guidewires High-performance guidewires designed to reach hard-to-access parts of the brain during stroke treatments, improving navigability through complex cerebral anatomy. Sold to hospitals and interventional neuroradiologists for use in neurovascular procedures.
• Microcatheters Specialized catheters for neurovascular interventions that work in conjunction with guidewires to access complex cerebral vasculature during stroke and aneurysm treatment procedures. Sold to hospitals and medical centers.
• Aspiration Catheters Catheter devices designed for aspiration-based neurovascular procedures, used in the treatment of acute ischemic stroke and other neurovascular conditions. Sold to hospitals and medical centers.

Quantifiable outcome

• Reduces stroke treatment times by approximately 30 minutes
• +1 more outcomes

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Stryker (Neurovascular): Acquired Cerenovus-focused assets via its $1.5B acquisition of Inari Medical and earlier buy of Penumbra competitor assets; operates a leading neurovascular portfolio including guidewires, microcatheters, and access devices. Direct competitor in the neurovascular access and stroke intervention market that Scientia Vascular serves.
• Penumbra: Leading neurovascular and peripheral vascular device company with strong positions in aspiration thrombectomy (Indigo system) and neurovascular access products. Direct competitor to Scientia's aspiration catheters and access devices in the stroke intervention market.
• MicroPort Scientific Corporation: Diversified medical device company with neurovascular products (via its endovascular and neurovascular businesses) including access and treatment devices. Directly competes with Scientia Vascular in neurovascular catheters and guidewires.

Broad incumbents

• Medtronic (Neurovascular): Global medical device leader that completed the $550M acquisition of Scientia Vascular in June 2026. Medtronic operates a broad neurovascular portfolio (e.g., Solitaire stent retriever, Riptide aspiration) and is now the parent platform integrating Scientia's access devices — the natural incumbent for comparison.
• Johnson & Johnson (Cerenovus): J&J's neurovascular business (Cerenovus) offers a broad portfolio including guidewires, microcatheters, and stroke intervention devices. A broad incumbent competitor in the same hospital customer segment for neurovascular procedures.

Emerging players

• Rapid Medical: Israel-based neurovascular company developing adjustable, minimally invasive devices for stroke and aneurysm treatment. An emerging competitor with overlapping product categories in neurovascular access and intervention.
• Vesalio: Emerging neurovascular company focused on next-generation stroke thrombectomy and access technologies. Competes in the same neurovascular access and stroke intervention space with innovative device approaches.
• Imperative Care: Neurovascular company developing a portfolio of access and thrombectomy technologies for ischemic and hemorrhagic stroke, including the Zoom aspiration system. An emerging player with direct overlap in aspiration catheters and neurovascular access.
• Wallaby Medical: Emerging neurovascular company offering a portfolio including the Avenir coil system and access devices for stroke and aneurysm treatment. A growing competitor in the neurovascular device space.

Regional players

• Balt: European-headquartered neurovascular and interventional neuroradiology device company with a portfolio of microcatheters, guidewires, and treatment devices. A regional player with comparable product offerings primarily serving European and emerging markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/scientiallc
• Facebookfacebook.com/scientia.vascular.5
• LinkedInlinkedin.com/company/scientia-vascular-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds3 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Scientia Vascular